Pyrazolopyrimidine derivative, its preparation method, and its use in preparation of medicines

一种吡唑并嘧啶、衍生物的技术，应用在吡唑并嘧啶衍生物及其制备领域，能够解决临床试验效果不理想、药物剂量影响疗效、毒副作用大等问题

Active Publication Date: 2014-02-12
GUANGXI WUZHOU PHARMA GRP
View PDF3 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the latest research has found that the clinical trials of these compounds are not ideal. One of the main reasons is that these compounds have relatively high toxicity and side effects, which limit the increase in drug dosage and affect the curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrazolopyrimidine derivative, its preparation method, and its use in preparation of medicines
  • Pyrazolopyrimidine derivative, its preparation method, and its use in preparation of medicines
  • Pyrazolopyrimidine derivative, its preparation method, and its use in preparation of medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1、4

[0538] Preparation of Example 1, 4-chloro-1H-pyrazolopyrimidine (2)

[0539]

[0540] 10mL POCl 3 (Phosphorus oxychloride) was added to 5g allopurinol (compound 1), DMF (N,N-dimethylformamide, 5mL) was slowly added dropwise at 0°C, and then DMA (N,N- Dimethylaniline, 1 mL) was stirred at room temperature for several minutes, and then the reaction system was heated to 120°C for 5 h. After the reaction was completely cooled, a large amount of ice water was added to quench the excess phosphorus oxychloride, and then extracted twice with ethyl acetate, and the ethyl acetate layer was spin-dried to obtain 3.2 g of solid, with a yield of 56.4%.

[0541] 1 H NMR (400MHz, DMSO-d 6 ): δ14.12 (s, 1H), 9.32 (s, 1H), 7.55 (s, 1H) ppm.

Embodiment 2

[0542] Preparation of Example 2, 4-(1H-pyrazolo-4-phenoxy)aniline (3a-1)

[0543]

[0544] Add p-aminophenol (0.55g, 5.5mmol) and sodium hydroxide (0.20g, 5.5mmol) into 10mL of water, stir at room temperature for 30 minutes, then add potassium carbonate (0.76g, 5.5mmol), while raising the temperature to 60°C, And slowly add the tetrahydrofuran solution of 4-chloro-1H-pyrazolopyrimidine (Intermediate 2) (0.94g, 6.6mmol) into the above reaction solution, stop the reaction after 1 hour, evaporate the tetrahydrofuran in the reaction system to dryness, The remaining system was extracted twice with ethyl acetate and water, the ethyl acetate layer was dried with anhydrous magnesium sulfate and spin-dried, and purified by column to obtain 4-(1H-pyrazolo-4-phenoxy)aniline (3a-1) , 0.77g, yield 62.1%.

[0545] 1 H NMR (400MHz, DMSO-d 6 ): δ14.07(s,1H),8.50(s,1H),7.67(s,1H),6.96(d,J=8.8Hz,2H),6.64(d,J=8.8Hz,2H),5.20 (s,2H) ppm. LCMS m / z: 228.1 [M+H].

Embodiment 3

[0546] Example 3, Preparation of 4-(1H-pyrazolo-4-phenoxy)-2-methylaniline (3a-2)

[0547]

[0548] Using intermediate (2) and 4-amino-3-methylphenol according to the synthesis method of intermediate (3a-1), intermediate (3a-2) was obtained with a yield of 64.2%.

[0549] 1 H NMR (400MHz, DMSO-d 6 ): δ14.04(s,1H),8.49(s,1H),7.65(s,1H),6.89(d,J=2.4Hz,1H),6.85(d,J=8.0Hz,1H),6.68 (d, J=8.4Hz, 1H), 4.94(s, 2H), 2.08(s, 3H) ppm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are a 4-position substituted pyrazolopyrimidine derivative having a structure represented by formula I, and a use thereof in drug preparation. The pyrazolopyrimidine derivative is used for preparing a kinase inhibitor, a drug for treating an autoimmune disease, an angiogenesis inhibitor, and an antitumor drug.

Description

technical field [0001] The invention belongs to the technical field of organic synthetic medicines, in particular to pyrazolopyrimidine derivatives, their preparation methods and their application in medicine preparation. Background technique [0002] Kinases widely exist in organisms, and they play a vital role in regulating cell proliferation, growth, differentiation, apoptosis, aging and other processes. Abnormal kinase activity can lead to the occurrence of many major diseases including cancer, various autoimmune diseases (such as lupus erythematosus, rheumatoid arthritis, psoriasis, etc.), diabetes, inflammation, etc. In view of this, kinases, as one of the most important targets for disease treatment, have become the hotspots of current research. [0003] According to the human gene map, 518 kinases have been identified in humans. The relationship between various kinases and tumors and various autoimmune diseases has been elucidated. For example: VEGFR2 (Vascular en...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04A61K31/519A61K31/5377A61P35/00A61P37/02
CPCC07D487/04A61P9/00A61P35/00A61P35/02A61P37/02A61P37/06A61P43/00A61K31/519
Inventor 杨胜勇魏于全
Owner GUANGXI WUZHOU PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap